Another look at the (endoscopic duodenal liner) ENDO trial, or how to avoid the burial of a valuable antidiabetic tool

Surg Obes Relat Dis. 2016 Mar-Apr;12(3):702-704. doi: 10.1016/j.soard.2015.08.503. Epub 2015 Aug 18.

Authors

Ricardo Cohen¹, Manoel Passos Galvão Neto², Carel Le Roux³

Affiliations

¹ The Center for Obesity and Diabetes, Oswaldo Cruz German Hospital, Sao Paulo, Brazil.
² Gastrobesocenter, Sao Paulo, Brazil.
³ Diabetes Complication Research Centre, UCD Conway Institute, School of Medicine and Medical Science, University College Dublin, Dublin, Ireland.

PMID: 26775047
DOI: 10.1016/j.soard.2015.08.503

No abstract available

Publication types

Editorial
Comment

MeSH terms

Bariatric Surgery
Burial
Duodenum / surgery*
Humans
Hypoglycemic Agents
Obesity, Morbid / surgery*

Substances

Hypoglycemic Agents